Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2008
10/23/2008WO2008127291A2 Advanced drug development and manufacturing
10/23/2008WO2008127285A2 Target peptides for ovarian cancer immunotherapy
10/23/2008WO2008127248A1 Gene defects and mutant alk kinase in human solid tumors
10/23/2008WO2008127199A1 Methods of controlling tumorigenesis and diagnosing the risk thereof
10/23/2008WO2008127192A1 Active-passive transponder
10/23/2008WO2008127139A1 Indicyanine dyes and the derivatives thereof for analysing biological micromolecules
10/23/2008WO2008127136A1 Method of determination of protein ligand binding and of the most probable ligand pose in protein binding site
10/23/2008WO2008127012A1 Method for focus adjustment about bio-chip
10/23/2008WO2008126940A1 Novel t cell
10/23/2008WO2008126920A1 Remedy for diabetes
10/23/2008WO2008126905A1 Evaluation method and screening method for substance having action of activating/suppressing innate immunity, agent and food product for activating/suppressing innate immune mechanism and method for producing the same
10/23/2008WO2008126780A1 High-sensitive detection method for protein in food
10/23/2008WO2008126664A1 Target substance detection element, target substance detection method, and method for producing target substance detection element
10/23/2008WO2008126517A1 Novel slc17-type transporter protein in mammal and use thereof
10/23/2008WO2008126446A1 Label for detecting biomolecule, method of producing the same and detection method using the same
10/23/2008WO2008126111A1 A chemosusceptibility rapid test for helicobacter pylori
10/23/2008WO2008126065A2 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/23/2008WO2008126002A2 Compound profiling method
10/23/2008WO2008125957A2 Method for identification and relative quantification of cellular proteins
10/23/2008WO2008125951A2 Integrated oil condition and level sensor
10/23/2008WO2008125840A1 Detection of bacteria or somatic cells in organic samples by atp based luminescence
10/23/2008WO2008125821A1 Method of mass spectrometry
10/23/2008WO2008125805A1 Metabolic profiling of fatty acid amides and its use in the diagnosis of and screening of drugs for schizophrenia
10/23/2008WO2008125788A1 Cyanine derivatives, fluorescent conjugates containing same and use thereof
10/23/2008WO2008125770A1 Method for detecting fungal contamination
10/23/2008WO2008125733A1 Immunoassay for quantification of an unstable antigen selected from bnp and probnp
10/23/2008WO2008125725A1 Modified routes of lipid metabolism, measuring oxidized ldl after fat loading.
10/23/2008WO2008125724A1 Estimation and biological consequences of oxidative metabolism
10/23/2008WO2008125681A1 Means and methods for assessing the risk of a cardiac intervention in patients suffering from a stable coronary heart disease based on gdf-15
10/23/2008WO2008125651A2 Biomarkers for multiple sclerosis
10/23/2008WO2008125637A1 Method for preparing a substrate for immobilising a cell, said substrate and uses thereof
10/23/2008WO2008125612A1 Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on egfr/csf-1/ca ix expression
10/23/2008WO2008125596A1 Methods and systems for performing differential radiography
10/23/2008WO2008125464A1 Compounds for the diagnosis of diseases associated with vcam expression
10/23/2008WO2008125420A2 Compounds for diagnosing apoptosis
10/23/2008WO2008125307A1 Ig-pCONSENSUS GENE VACCINATION PROTECTS FROM ANTIBODY-DEPENDENT IMMUNE PATHOLOGY IN AUTOIMMUNE DISEASE
10/23/2008WO2008125262A1 Autoimmune regulation of prostate cancer by annexin a3
10/23/2008WO2008124936A1 Method of producing bioactive paper
10/23/2008WO2008124933A1 Carbon and nitrogen-regulating gene and protein and modulation thereof
10/23/2008WO2008124925A1 Fusarium detection method
10/23/2008WO2008124920A1 Urine based detection of a disease state caused by a pneumococcal infection
10/23/2008WO2008124916A1 Methods for the diagnosis and risk assessment of plasmalogen deficiency mediated diseases of aging
10/23/2008WO2008124883A1 Method of determining the amount of carbon dioxide sequestered into the ocean as a result of ocean nourishment
10/23/2008WO2008124853A1 Optical measurement method for molecular detection using relaxation measurement in optically anisotropic nanoparticles
10/23/2008WO2008105824A3 Direct detection of ligand-antiligand interactions by nanoscale switching
10/23/2008WO2008104679A3 Medium for the detection and/or identification of bacteria
10/23/2008WO2008098129A3 Materials and methods for detecting and treating peritoneal ovarian tumor dissemination involving tissue transglutaminase
10/23/2008WO2008096236A8 Egg candling facility and method with air cell detection
10/23/2008WO2008094875A3 Methods for treating bone loss and bone disease associated with chronic kidney disease
10/23/2008WO2008092094A9 Method and materials for detection, diagnosis and management of ovarian cancer
10/23/2008WO2008090332A3 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
10/23/2008WO2008086035A3 Split mutant hydrolase fusion reporter and uses thereof
10/23/2008WO2008085182A3 Supra nanoparticle assemblies and methods of making and using the assemblies
10/23/2008WO2008081094A3 Method for the functional measurement of plasmatic thromboduline activity
10/23/2008WO2008078193A3 Method of diagnosing and stratifying anti-phospholipid syndrome
10/23/2008WO2008078023A3 Method for characterising the organic material of a liquid effluent
10/23/2008WO2008076784A3 Methods and compositions for treating il-4 or il-13 related fibrosis related pathologies
10/23/2008WO2008075181A3 Apparatus and method for measuring the coagulation characteristics of a test liquid
10/23/2008WO2008073635A9 Automatable artificial immune system (ais)
10/23/2008WO2008073316A3 Identification and isolation of acute myeloid leukemia stem cells
10/23/2008WO2008073292A3 Method for protecting renal tubular epithelial cells from radiocontrast nephro parhy (rcn)
10/23/2008WO2008072192A3 Biological assay substrate and method and device for producing such substrate
10/23/2008WO2008067196A3 Methods for identifying inhibitors of solute transporters
10/23/2008WO2008065540A3 Method for the detection of post-translational modifications
10/23/2008WO2008063779A3 Cells expressing alpha-synuclein and uses therefor
10/23/2008WO2008063151A3 Reaction sensing in living cells
10/23/2008WO2008060785A9 Prevention of tissue ischemia, related methods and compositions
10/23/2008WO2008060783A3 Ccr2 antagonists for treatment of fibrosis
10/23/2008WO2008060607A3 Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
10/23/2008WO2008058517A3 Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin ii
10/23/2008WO2008057470A3 Identification of bitter ligands that specifically activate human t2r receptors and related assays for identifying human bitter taste modulators
10/23/2008WO2008054947A8 Structure of acid beta-glucosidase and methods for identifying therapeutic agents
10/23/2008WO2008054534A9 Screening systems utilizing rtp801
10/23/2008WO2008050165A8 Container for analyzing liquid
10/23/2008WO2008048410A3 Diagnostic methods and genetic markers for alzheimer disease
10/23/2008WO2008045919A3 Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways
10/23/2008WO2008021653A3 Method of measurement of cellular hemoglobin
10/23/2008WO2008019291A3 Anti-alix antibodies and hybridomas
10/23/2008WO2008014314A3 Biomarkers of mild cognitive impairment and alzheimer's disease
10/23/2008WO2008013914A9 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes
10/23/2008WO2008005418A3 Assays for tak1 activity
10/23/2008WO2008005375A3 Kidney toxicity biomarkers
10/23/2008WO2007143295A3 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
10/23/2008WO2007139946A3 Gpcr ligands identified by computational modeling
10/23/2008WO2007134274A3 Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy
10/23/2008WO2007133457A3 Electrochemical test sensor with reduced sample volume
10/23/2008WO2007127160A3 Agrm2 antigen
10/23/2008WO2007123765A3 Neutrokine-alpha and neutrokine-alpha splice variant
10/23/2008WO2007123680A3 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
10/23/2008WO2007106707A3 Identification and engineering of antibodies with variant heavy chains and methods of using same
10/23/2008WO2007105143A8 Sensor device with alternating excitation fields
10/23/2008WO2007095746A9 Cancerous disease modifying antibodies
10/23/2008WO2007048127A3 Fc labeling for immunostaining and immunotargeting
10/23/2008WO2005113798A3 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
10/23/2008US20080263689 Screening/monitoring rate of internalization of insulin receptors in insulin-stimulated hepatocytes; identifying modulators of insulin clearance and secretion; treating insulin resistance
10/23/2008US20080263685 Transgenic non-human animal expressing metabotropic glutamate receptor 1 in a melanocyte-specific manner for identifying modulators for prevention and treatment of cell proliferative disorders
10/23/2008US20080263684 Pik4ca As Modifier of the Rac Pathway and Methods of Use
10/23/2008US20080263683 Animal models expression receptors for advanced glycation end-products (RAGE) and inducible nitric oxide synthase for use as tool in identifying modulators for treatment and prevention of glomerular disorders
10/23/2008US20080262748 Method And Device For Biomass Determination In A Medium, In Particular A Medium Containing Biological Cells, And Mesurement Apparatus Implementing Same
10/23/2008US20080262746 Method and device for predicting physiological values
1 ... 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 ... 3937